Overzicht van nieuwe geneesmiddelen (ATC-codes) in 2024 met de vergoeding per jaar
- Raming voor de totale Zvw-populatie
| Introductiejaar | ATC-code | 2024 |
|---|---|---|
| 2024 | A06AH05 Naldemedine | 3.562 |
| C01EB24 Mavacamten | 680.281 | |
| C02KX54 Macitentan met tadalafil | 25.566 | |
| C10AX18 Volanesorsen | 134.375 | |
| C10BA10 Bempedoinezuur met ezetimib | 38.664 | |
| J05AX28 Bulevirtide | 485.406 | |
| L02BX04 Relugolix | 141.977 | |
| L04AD03 Voclosporine | 44.012 | |
| L04AF02 Baricitinib | 339.304 | |
| L04AF08 Ritlecitinib | 17.079 | |
| L04AJ03 Pegcetacoplan | 1.408.615 | |
| L04AJ05 Avacopan | 1.769.890 | |
| N02CD07 Atogepant | 160.452 | |
| N03AX26 Fenfluramine | 533.695 | |
| N04BA07 Foslevodopa met decarboxylaseremmer | 4.915.697 | |
| R01AD59 Mometason combinatiepreparaten | 1.945 | |
| R03DX10 Benralizumab | 3.890.847 | |
| R03DX11 Tezepelumab | 506.033 | |
| S01EE51 Latanoprost met netarsudil | 203.362 | |
| Totaal | 15.300.761 |